Σάββατο 3 Αυγούστου 2013

Rx-360 July 2013 US Congress Concerns Over Potential Heparin Shortages

U.S. lawmakers are concerned a Chinese company's planned $4.7 billion acquisition of
pork producer Smithfield Foods could affect the safety and availability of heparin. Members
of the House Committee on Energy and Commerce wrote to Smithfield on July 24 asking the
company to turn over information on its production of crude heparin, the raw ingredient used
to make the drug. As well as being the world's largest pork producer, with more than 46,000
employees in 25 U.S. states and four countries, Smithfield is also a major supplier of crude
heparin.